Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, stab-free way to treat diabetes and obesity.

Diabetics given the pill called orforglipron lost 16 pounds, or 7.9% of their body weight, over a 40-week period.

Semaglutide medications like Ozempic and Wegovy have exploded in popularity in recent years due to their effectiveness in diabetes control and weight ... issues are the most common side effects ...

Weight-loss drugs can be life-changing for people who have struggled to lose weight, however, some people who take them experience unpleasant side effects. In 2024, roughly 5 per cent of Britons had ...

Weight-loss drugs can be life-changing for people who have struggled to lose weight, however, some people who take them experience unpleasant and concerning side effects. In 2024, roughly 5 per cent ...

Injectible weight-loss drugs such as Ozempic can be life ... GP and medical director of Cosmedics Skin Clinics, now “Ozempic feet” is “emerging as another potential side effect gaining attention”.

Injectible weight-loss drugs such as Ozempic ... Skin Clinics, now “Ozempic feet” is “emerging as another potential side effect gaining attention”. “Much like the face, the feet can ...

Weight-loss drugs can be ... used an injectable glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications known under brand names such as Wegovy, Ozempic and Mounjaro, which ...

Weight-loss drugs can be ... used an injectable glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications known under brand names such as Wegovy, Ozempic and Mounjaro, which ...